Animal studies have shown that GLP-1 receptor agonists can reduce the desire for high-fat and high-sugar foods, which could contribute to weight loss
3,11,12,30 DPP-4 inhibitors have not been shown to cause weight gain or hypoglycemia unless used in combination with other antihyperglycemic agents, such as insulin or sulfonylureas
Small adjustments in your routine, combined with the right clinical products, can make a world of difference in preventing the return of oily flakes
It is worth mentioning that Novo Nordisk also submitted a Priority Review Voucher (PRV) to speed up the NDA review, which can shorten the NDA review cycle from the standard 10 months to 6 months
This product is not recommended for children, pregnant or breastfeeding women, or anyone under antihypertensive or antidiabetic treatment
Anatomy and physiology of the colon and rectum